Table 4.
Significant independent predictors of LV function and carotid remodeling at the end of follow-up
| Predictors | 95% CI | p value |
|---|---|---|
| LV systolic function | ||
| Cholesterol | 2.647–45.433 | 0.001 |
| ET-1 | 0.002–0.778 | 0.007 |
| LV diastolic function | ||
| Urine volume (ml/day) | 0.401–1.004 | 0.001 |
| Diabetes mellitus type 2 | 0.346–0.997 | 0.007 |
| Hemoglobin | 0.485–0.893 | 0.010 |
| CCA IMT | ||
| Female gender | 0.002–0.898 | 0.042 |
| Body mass index | 1.035–2.304 | 0.033 |
| C-reactive protein | 1.124–2.200 | 0.008 |
| ET-1 | 1.874–3.007 | 0.024 |
| CCA diameter | ||
| Serum albumin | 0.134–0.809 | 0.015 |
| Hemoglobin | 0.741–0.991 | 0.037 |
| Low-density lipoprotein | 1.131–14.591 | 0.032 |
| Age | 1.018–1.383 | 0.029 |